www.mercurynews.com
4 months agoHealth
Stanford-led study offers relief to children with dangerous food allergies, leading to FDA drug approval
First-ever food allergy medication omalizumab reduces reaction risk
Patients need to avoid allergens and have epinephrine despite medication use [ more ]